TABLE 2.

Correlations Between Selected Measurements of Tissue and Serum Markers among ‘Baseline Samples’ (n=31).

	CALCITONIN	PAP	PSA	AURKA-N	NKX3-1	AR-N	RB1	AR-C	AURKA-C	UBE2C-C	Ki67	UBE2C-N	SOMATOSTATIN	Tp53	StdCHRA	CEA
CALCITONIN	1	0.21	0.68	0.24	0.15	0.19	−0.14	−0.08	−0.19	−0.14	−0.20	−0.09	0.03	−0.04	0.10	−0.04
PAP	0.21	1	0.12	0.27	0.17	0.22	0.28	−0.07	−0.16	−0.13	−0.17	−0.09	0.19	−0.11	0.11	−0.05
PSA	0.68	0.12	1	0.28	0.44	0.50	0.01	−0.11	−0.10	−0.31	−0.43	−0.25	0.06	−0.21	−0.01	−0.12
AURKA-N	0.24	0.27	0.28	1	0.43	0.51	0.47	−0.15	−0.18	−0.34	−0.42	−0.28	−0.10	−0.25	−0.12	−0.23
NKX3-1	0.15	0.17	0.44	0.43	1	0.82	0.59	0.17	0.10	−0.40	−0.61	−0.49	−0.19	−0.17	−0.30	0.13
AR-N	0.19	0.22	0.50	0.51	0.82	1	0.64	0.33	0.20	−0.11	−0.38	−0.22	−0.05	−0.20	−0.15	−0.23
RB1	−0.14	0.28	0.01	0.47	0.59	0.64	1	0.30	−0.03	−0.21	−0.42	−0.13	−0.07	−0.27	−0.13	−0.17
AR-C	−0.08	−0.07	−0.11	−0.15	0.17	0.33	0.30	1	0.37	0.45	0.06	0.13	0.13	−0.17	−0.12	−0.08
AURKA-C	−0.19	−0.16	−0.10	−0.18	0.10	0.20	−0.03	0.37	1	0.41	0.12	−0.02	−0.06	−0.24	−0.03	−0.17
UBE2C-C	−0.14	−0.13	−0.31	−0.34	−0.40	−0.11	−0.21	0.45	0.41	1	0.65	0.34	0.00	−0.05	−0.01	−0.10
Ki67	−0.20	−0.17	−0.43	−0.42	−0.61	−0.38	−0.42	0.06	0.12	0.65	1	0.60	0.25	0.51	0.27	0.29
UBE2C-N	−0.09	−0.09	−0.25	−0.28	−0.49	−0.22	−0.13	0.13	−0.02	0.34	0.60	1	0.56	0.57	0.03	−0.01
SOMATOSTATIN	0.03	0.19	0.06	−0.10	−0.19	−0.05	−0.07	0.13	−0.06	0.00	0.25	0.56	1	0.41	−0.12	−0.03
Tp53	−0.04	−0.11	−0.21	−0.25	−0.17	−0.20	−0.27	−0.17	−0.24	−0.05	0.51	0.57	0.41	1	−0.08	0.47
StdCHRA	0.10	0.11	−0.01	−0.12	−0.30	−0.15	−0.13	−0.12	−0.03	−0.01	0.27	0.03	−0.12	−0.08	1	−0.05
CEA	−0.04	−0.05	−0.12	−0.23	0.13	−0.23	−0.17	−0.08	−0.17	−0.10	0.29	−0.01	−0.03	0.47	−0.05	1

Strong correlations (≥ 0.5) are highlighed in black. Abbreviations are described in the Figure 1B legend.